Newsroom
Sorted by: Latest
-
Arcadian Risk Capital Appoints Michael Saitta as Global Head of Tax and Representations & Warranties Insurance
HAMILTON, Bermuda--(BUSINESS WIRE)--Arcadian Risk Capital (“Arcadian”), the Bermuda-headquartered managing general agent (MGA), today announced the appointment of Michael Saitta as Global Head of Tax and Representations & Warranties (“TRW”) Insurance, based in New York. Michael will lead the strategic expansion, underwriting operations and portfolio management of Arcadian’s global TRW business. Michael joins Arcadian with extensive experience spanning Big Four tax advisory and leading globa...
-
Equity Medical Acquires Majority Stake in Skylight Health Research, Expanding National Site Network Into New England and the Mountain West
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Equity Medical, LLC (“Equity Medical”), a physician-owned, integrated national site network conducting high-performance Phase IA–IV clinical research, today announced it has completed the acquisition of a majority stake in Skylight Health Research, Inc. (“Skylight”), a clinical research site network with locations in Burlington, Massachusetts and Colorado Springs, Colorado. Terms of the transaction were not disclosed. The acquisition extends Equity...
-
Fort George Belize Joins Autograph Collection Hotels, Bringing the History, Culture and Spirit of Belize City to Life Through a Distinctive Waterfront Experience
MIAMI--(BUSINESS WIRE)--Fort George Belize, Autograph Collection, part of Marriott Bonvoy’s distinctive portfolio of independent hotels, announces its debut as a landmark waterfront retreat in the historic Fort George neighborhood. Celebrated for its individual character and story, the hotel enters a new chapter that honors its longstanding connection to Belize City while inviting travelers to experience the destination’s history, culture, and Caribbean spirit through a refreshed and distinctly...
-
Sycamore Launches Platform to Build Self-Improving Enterprise-Grade Agentic Software
PALO ALTO, Calif.--(BUSINESS WIRE)--Sycamore Labs, Inc. announced the general availability of their AI platform that enables organizations to build custom, enterprise-grade agentic software using the expertise of the people who know their businesses best. With Sycamore Build, employees can transform complex business processes into working agents and applications, without needing to know how to code. For decades, enterprises have relied on off-the-shelf software that requires businesses to adapt...
-
Fourthline and Veridas Complete Merger to Create a European Leader in Bank-Grade Digital Identity
AMSTERDAM & PAMPLONA, Spain--(BUSINESS WIRE)--Fourthline and Veridas today announce the completion of their merger, first announced on 16 July 2026. The transaction closed on 3 November 2026 following the satisfaction of all closing conditions. The funding will be used to accelerate product innovation, pursue strategic M&A, refinance debt, and support a shareholding reorganization that includes partial liquidity for Veridas shareholders. Both businesses will be EBITDA-positive at close. The...
-
DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026
NEW YORK--(BUSINESS WIRE)--DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026. Management to host conference call and webcast at 5:00 p.m. ET on that day....
-
Medincell - UZEDY®: Q3 U.S. Net Sales Reach $85M, Up 96% Year-on-Year; 2026 Revenue Outlook Raised to $290-310M
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: UZEDY® U.S. net sales reached $85M in Q3 2026, up 96% year-on-year, according to third-quarter results reported today by Medincell’s (Paris:MEDCL) partner Teva Pharmaceuticals (NYSE and TASE: TEVA). Teva raised its 2026 UZEDY® revenue outlook to $290-$310M, from $270-$290M previously. UZEDY® generated $225M in U.S. net sales over the first nine months of 2026, exceeding the $191M reported for full-year 2025. UZEDY® commercial performance in...
-
Medincell - UZEDY® : les ventes nettes atteignent 85 M$ au troisième trimestre 2026, en hausse de 96% sur un an ; les prévisions de ventes 2026 relevées à 290-310 M$
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Les ventes nettes d’UZEDY® aux États-Unis ont atteint 85 M$ au troisième trimestre 2026, en hausse de 96% sur un an, selon les résultats trimestriels publiés ce jour par Teva Pharmaceuticals (NYSE et TASE : TEVA), partenaire de Medincell (Paris:MEDCL). Teva a relevé ses prévisions de ventes d’UZEDY® pour l’année 2026 à 290-310 M$, contre 270-290 M$ précédemment. Sur les neuf premiers mois de 2026, les ventes nettes d’UZEDY® aux États-Unis o...
-
Energy Transfer Reports Third Quarter 2026 Results
DALLAS--(BUSINESS WIRE)--Energy Transfer LP (TXSE:ET) (“Energy Transfer” or the “Partnership”) today reported financial results for the quarter ended September 30, 2026. Energy Transfer reported net income attributable to partners for the three months ended September 30, 2026 of $1.21 billion compared to $1.02 billion for the three months ended September 30, 2025. For the three months ended September 30, 2026, net income per common unit (basic) was $0.33. Adjusted EBITDA for the three months en...
-
SpaceCorp Files N-2 Registration Statement for Proposed Initial Public Offering
LOS ANGELES--(BUSINESS WIRE)--SpaceCorp, a closed-end investment fund focusing on the space economy and advised by FutureCorp Asset Management LLC, today announced that it has publicly filed a Form N-2 registration statement with the U.S. Securities and Exchange Commission for the proposed initial public offering of its shares of common stock. The number of shares of common stock to be offered and the size of the fund have not yet been determined. SpaceCorp intends to list its common stock on t...